Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancerCristina Guarducci, Ilenia Migliaccio|npj Breast Cancer|2018Cited by 134
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast CancerCristina Guarducci, Rinath Jeselsohn|Clinical Cancer Research|2024Cited by 34
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast CancerFrancisco Hermida‐Prado, Rinath Jeselsohn, Yingtian Xie et al.|Cancer Research|2023Cited by 15
Figure 5 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast CancerFrancisco Hermida‐Prado, Rinath Jeselsohn, Yingtian Xie et al.|Unknown|2023Cited by 0
Supplementary Fig. S6 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast CancerFrancisco Hermida‐Prado, Rinath Jeselsohn, Yingtian Xie et al.|Unknown|2023Cited by 0